Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spirytus skażony hibitanem is a topical antiseptic solution developed by Zakład Farmaceutyczny AMARA. It contains 0.5% chlorhexidine (typically as chlorhexidine gluconate) dissolved in ethanol. The product is primarily used for the disinfection of skin prior to invasive procedures such as injections, blood sampling, and surgical interventions, as well as for hygienic hand disinfection. Chlorhexidine provides persistent antimicrobial activity by disrupting microbial cell membranes, while ethanol offers rapid bactericidal effects through protein denaturation and lipid dissolution. It is an over-the-counter (OTC) product in Poland.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine + ethanol.